Lana Medical Company (TADAWUL: 9587)
Saudi Arabia
· Delayed Price · Currency is SAR
36.70
+1.20 (3.38%)
Nov 21, 2024, 2:52 PM AST
Lana Medical Company Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| TTM
| FY 2022 | FY 2021 |
| Dec '22 Dec 31, 2022 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 5.49 | 5.49 | 6.59 |
| Depreciation & Amortization | 1.53 | 1.53 | 1.08 |
| Loss (Gain) From Sale of Assets | - | - | -0.01 |
| Provision & Write-off of Bad Debts | 1.79 | 1.79 | - |
| Other Operating Activities | 0.55 | 0.55 | 1.29 |
| Change in Accounts Receivable | -2.18 | -2.18 | -10.23 |
| Change in Inventory | -0.02 | -0.02 | 0.7 |
| Change in Accounts Payable | -0.04 | -0.04 | 0.4 |
| Change in Other Net Operating Assets | -1.66 | -1.66 | -4.78 |
| Operating Cash Flow | 5.45 | 5.45 | -4.95 |
| Capital Expenditures | -5.1 | -5.1 | -7.22 |
| Sale of Property, Plant & Equipment | - | - | 0.01 |
| Other Investing Activities | - | - | 0.11 |
| Investing Cash Flow | -5.1 | -5.1 | -7.1 |
| Long-Term Debt Issued | 1.77 | 1.77 | 0.51 |
| Long-Term Debt Repaid | -2.34 | -2.34 | -1.52 |
| Net Debt Issued (Repaid) | -0.57 | -0.57 | -1.02 |
| Issuance of Common Stock | - | - | 13 |
| Financing Cash Flow | -0.57 | -0.57 | 11.98 |
| Net Cash Flow | -0.21 | -0.21 | -0.06 |
| Free Cash Flow | 0.36 | 0.36 | -12.17 |
| Free Cash Flow Margin | 0.87% | 0.87% | -38.06% |
| Free Cash Flow Per Share | 0.12 | 0.12 | -5.56 |
| Cash Interest Paid | 0.14 | 0.14 | - |
| Levered Free Cash Flow | -1.8 | -1.8 | - |
| Unlevered Free Cash Flow | -1.68 | -1.68 | - |
| Change in Net Working Capital | 2.18 | 2.18 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.